(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 3.58% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 0.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.
Innospec's revenue in 2025 is $1,786,000,000.On average, 1 Wall Street analysts forecast IOSP's revenue for 2025 to be $46,175,998,150, with the lowest IOSP revenue forecast at $46,175,998,150, and the highest IOSP revenue forecast at $46,175,998,150.
In 2026, IOSP is forecast to generate $49,470,718,018 in revenue, with the lowest revenue forecast at $49,470,718,018 and the highest revenue forecast at $49,470,718,018.